C.R. Bard 2142275 - PowerLoc MAX Port Access Kit, Without Y-Site, 22 Gauge x .75", 5/CS

C.R. Bard 2142275 - PowerLoc MAX Port Access Kit, Without Y-Site, 22 Gauge x .75", 5/CS

PowerLoc MAX Port Access Kit

Designed to standardize port access procedures. Provides the convenience of necessary kit components in a common package. Kit components are organized to facilitate sterile "best practices" for port access related procedures. Assists clinicians in complying with guidelines for sterile port access outlined by nursing societies and the CDC.

Procedural Checklist included in every kit:

• Educate and assist in sterile port access technique.
• Convenient documentation and tracking of port access procedure.
• Procedural checklist for simplified protocol documentation.

Port Access Kit

• Designed to standardize port access procedures.
• Provides the convenience of necessary kit components in a common package.
• Kit components are organized to facilitate sterile best practices for port access related procedures.

Procedural Checklist included in every kit:

• Educate and assist in sterile port access technique.
• Convenient documentation and tracking of port access procedure.

Kit Components

• 1 Your Preferred Bard Huber Needle.
• 1 Syringe, Sodium Chloride (Saline) 0.9%, 10mL.
• 1 Chloraprep One-Step Applicator.
• 1 Dressing, Transparent.
• 4 Gauze Pad, 2 in. x 2 in.
• 2 Gloves, Non-Latex, Sterile.
• 1 Procedure Checklist.
• 1 Mask.
• 1 Prep Pad, Alcohol.
• 1 Prep Pad, Skin Protectant.
• 1 Tape Strips, Anchor (3 per).
• 1 Towel, Absorbent.
• 1 Dressing Change Label.

KIT Features

An estimated 3-6% of ports placed will develop a port-related infection, impacting a cancer patients already challenging treatment.1, 2, 3, 4, 5 Port-related infections may be due to the initial access or in-dwell of an infusion set in the patients port.

Port Access Related Implications

For the patient:

• Port removal.
• Chemotherapy/treatment interruption.
• Hospital in-patient stay.
• Secondary complications from infection.
• Placement of a 2nd device that may not offer the benefits of a port.

For the facility:

• Port removal.
• Potential hospital stay.
• Additional procedures and devices.
• Less or lack of reimbursement due to recent CMS changes regarding central line infections.

Proper Port-Access Technique Matters

Nearly 80% of Oncology Nurses surveyed by Bard cite poor sterile technique, site prep or access procedures as the likely cause for port access related infections.

Help clinicians to meet the following

• Oncology Nursing Society (ONS) Guidelines.
• Infusion Nursing Society (INS) Standards of Practice.
• Centers for Disease Control (CDC) Guidelines.
• Occupational Safety & Health Administration (OSHA) Guidelines.
• The Joint Commission (JCAHO) National Patient Safety Goals.

Before Opening

• Assemble any supplementary components.
• Wash hands.
• If applicable, carefully remove old dressing and discard in appropriate receptacle.

NOTE: Components are generally arranged in order of use from top to bottom.

• Open package containing sterile insertion/dressing kit and Safety Infusion Set device.
• Remove CSR wrapped kit and place onto work surface with folds up.
• Remove face mask from outer folds of wrap and don.
• Remove gloves from outer folds of wrap.

• Aseptically unfold wrap to expose insertion dressing kit components to create sterile field.
• Aseptically open sterile field SF saline syringe and any supplementary sterile components and drop onto sterile field.
• Don sterile prep gloves.
• Aseptically drape site with sterile drape to create sterile field.
• Prepare insertion site using ChloraPrep Solution One-Step applicator. Consult the supplied manufacturers instructions for details, if needed.
• Remove and discard gloves.
• Don second pair of sterile gloves.
• Aseptically prepare the Safety Infusion Set.
• Insert the needle into the port using aseptic technique. Consult the supplied Safety Infusion
• Set device instructions for details if needed.
• Secure device (use sterile gauze and adhesive strips if applicable) and apply sterile occlusive transparent dressing per institutional policy.
• At the end of the procedure, remove gloves and dispose of used materials per institutional protocol.